Author(s):
Srikanta Chandra, Avik Das, Tathagata Roy, Preeta Bose, Susanta Paul, Lucky Mukherjee, Arijit Das
Email(s):
troy@jisuniversity.ac.in
DOI:
10.5958/0974-360X.2021.00321.8
Address:
Srikanta Chandra1, Avik Das2, Tathagata Roy3, Preeta Bose3, Susanta Paul3, Lucky Mukherjee4, Arijit Das5
1Assistant Professor, Jakir Hossain Institute of Pharmacy, Department of Pharmacology, Raghunathganj, Murshidabad, 742225.
2Assistant Professor, Gupta College of Technological Sciences, Department of Pharmacology, Asansol, West Burdwan, West Bengal, 713301.
3Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
4Assistant Professor, Sister Nivedita University, Kolkata.
5Assistant Professor, Bharat Technology, Uluberia, Howrah.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2021
Cite this article:
Srikanta Chandra, Avik Das, Tathagata Roy, Preeta Bose, Susanta Paul, Lucky Mukherjee, Arijit Das. Emergent Strategy in Management of Inflammatory Bowel Disease: A Narrowed in on Novel Drugs. Research J. Pharm. and Tech. 2021; 14(3):1811-1814. doi: 10.5958/0974-360X.2021.00321.8